Related Content
Download content relating to this event and topic.
Bringing together top minds from South Korea, Japan, China, and Taiwan, #CGTEA2025 drives breakthroughs in regenerative medicine, gene editing, and personalised therapies—fueling collaboration across biopharma, academia, and CDMOs.
Returning after its successful run in 2023, Cell & Gene Therapy East Asia 2025 (#CGTEA2025) will once again bring together the brightest minds and industry leaders from South Korea, Japan, China, and Taiwan to explore the latest breakthroughs in regenerative medicine. As the region accelerates innovation in gene editing, cell therapy, and personalised medicine, #CGTEA2025 will serve as a critical hub for fostering collaboration between biopharma companies, academic and research institutions, and CDMOs.
This year’s conference will focus on cutting-edge advancements in gene-modified cell therapies, scalable manufacturing for next-generation therapeutics, regulatory frameworks shaping the East Asian market, and strategies to drive commercial success in cell and gene therapy. With an emphasis on bridging research with clinical and commercial applications, the event will provide unparalleled insights into the future of precision medicine.
Under the umbrella of Biologics World Korea 2025 (#BWK2025), #CGTEA2025 will be co-located with Biologics Manufacturing Korea 2025 (#BMK2025) and ADC & Bioconjugate East Asia 2025 (#ADCBio2025), creating a dynamic cross-disciplinary platform for networking, knowledge-sharing, and business growth. Whether you're looking to gain regulatory insights, explore investment opportunities, or forge strategic partnerships, this is the premier event to connect with East Asia’s key players in the cell and gene therapy landscape.
View the Key Themes for
CGT East Asia 2025
Register today to secure your ticket.
Our selected experts will share insights on the latest trends, challenges, and developments in this dynamic field. Engage in unique discussions, learn about cutting-edge scientific discoveries, and explore the future of biopharmaceuticals with these influential thought leaders.
Dr. Saluja is the Head of Clinical Development at International Vaccine Institute (IVI), whose mission is to discover, develop and deliver safe, effective, and affordable vaccines for Global Health. He has 20 years of experience working in industry, academia and resource-limited settings in both patient care and clinical research. He joined IVI in 2017 and his main areas of research includes epidemiology studies, pre-clinical research, and vaccine clinical trials (phase I-IV). In his current role, he is responsible for capacity building in terms of trainings and infrastructure in low- & middle-income countries, designing clinical trials, grant writing, regulatory interactions, overseeing departmental activities like medical writing, study startup, study execution, regulatory submissions, pharmacovigilance and impact evaluation. He has many publications in national and international Journals to his credit. Dr. Saluja has received many awards & recognitions from academia and industry alike.
Sia Pheng Tan is an agile, strategic, and accomplished Quality Leader with a wealth of experience in global GMP regulated environments such as Amgen, GSK Biologics, Lonza, Alcon (Novartis), Baxter Healthcare, Becton Dickinson & Edwards Lifesciences. A successful track record across quality operations, audits, suppliers’ management, quality management system, validation & storage & distribution. A natural leader able to mentor, develop and manage high performing teams.
Highly motivated, creative, and goal-oriented process manager and project manager over twenty two (22) years of experience in Pharmaceutical Industry from Janssen Vaccine, Samsung Biologics, SK Chemical, and Cha Biotech in Korea. Effective working based on knowledge of three areas of process development, manufacturing and engineering.
Overcoming Challenges in Cell & Gene Therapy Production through Advanced Technologies.
Choose a plan that fits your role, company, and industry.
Early Bird
Applicable to company profiles (headquartered within the APAC region):
Job Profiles: Manufacturing, Bioprocessing, Production, USP, DSP, Operations, Site Heads, Drug Substance and Product Manufacturing, Process Development, Quality, Analytics and other related technical designations
Early Bird
Applicable to company profiles (headquartered outside of the APAC region):
Job Profiles: Manufacturing, Bioprocessing, Production, USP, DSP, Operations, Site Heads, Drug Substance and Product Manufacturing, Process Development, Quality, Analytics and other related technical designations
Early Bird
Applicable to company profiles:
Job Profiles: Business Development, Marketing, and Sales
Be the first in line! Register your interest now to get exclusive access to Super Early-Bird tickets - the lowest prices available - before they go live.
Join the roster of esteemed colleagues to discuss what you or your company are bringing to the biopharmaceutical industry.
Contact the IMAPAC to learn about our sponsorship process, rates and more.
Visit the event page to view more content.
Download content relating to this event and topic.
Visit the event page to view more content.
Visit the awards page to view more content.
To stay informed about event updates, including date, venue, and agenda, please subscribe to our newsletter on our event website. You can also follow our official social media channels for real-time updates and announcements.
The conference will provide a comprehensive learning experience covering various aspects of the dynamic biopharmaceutical industry, ensuring attendees gain valuable insights and knowledge.
We are committed to ensuring the safety and well-being of all attendees. We will implement rigorous safety measures in line with local health guidelines and regulations. Specific safety measures will be communicated closer to the event date to ensure they align with the most up-to-date health recommendations. Rest assured, your safety is our priority.
Yes, we have a cancellation and refund policy in place. Please refer to our “Cancellation Policy” on our website for details on how to request a refund if you are unable to attend.
We welcome presentation submissions. If you’re interested in speaking at the event, please visit this page on our website for submission guidelines and deadlines.
Our event is designed to cater to a wide range of professionals within the biopharmaceutical industry, including researchers, scientists, executives, regulatory experts, and professionals involved in drug development and manufacturing.
Participants can expect to gain insights from industry experts, network with peers, and stay up-to-date with the latest trends and innovations in biopharmaceuticals
Yes, we have networking sessions, workshops, and social events scheduled throughout the event to facilitate connections and collaborations among attendees.
Yes, we offer sponsorship and exhibition opportunities for businesses and organizations. Please visit our this page on our website for more information.
To register for the event, you'll find multiple "register" buttons on this page to get started. You’ll find detailed instructions and options for registration, including pricing and deadlines.
Don't miss out on unique networking, speaking and sponsorship opportunities.